Advances in Retinopathy

Retinopathy is any damage to the retina of the eyes, which may cause vision impairment. Retinopathy often refers to retinal vascular disease, or damage to the retina caused by abnormal blood flow. Age-related macular degeneration is technically included under the umbrella term retinopathy but is often discussed as a separate entity. Retinopathy, or retinal vascular disease, can be broadly categorized into proliferative and non-proliferative types. Frequently, retinopathy is an ocular manifestation of systemic disease as seen in diabetes or hypertension. Diabetes is the most common cause of retinopathy in the U.S. as of 2008. Diabetic retinopathy is the leading cause of blindness in working-aged people. It accounts for about 5% of blindness worldwide and is designated a priority eye disease by the World Health Organization.

Sample Chapter(s)
preface (49 KB)
Components of the Book:
  • Chapter 1
    Analysis of Korean Retinal Specialists’ Opinions on Implanting Diffractive Multifocal Intraocular Lenses in Eyes with Underlying Retinal Diseases
  • Chapter 2
    Fructus lycii: A Natural Dietary Supplement for Amelioration of Retinal Diseases
  • Chapter 3
    Diabetic Retinopathy in Pregnancy - A review
  • Chapter 4
    Continuous Subcutaneous Insulin Infusion Therapy is Associated with Reduced Retinopathy Progression Compared with Multiple Daily Injections of Insulin
  • Chapter 5
    Retinal Venular Tortuosity and Fractal Dimension Predict Incident Retinopathy in Adults with Type 2 diabetes: the Edinburgh Type 2 Diabetes Study
  • Chapter 6
    Recent Advancements in the Medical Treatment of Diabetic Retinal Disease
  • Chapter 7
    Small-Molecule Modulation of PPARs for the Treatment of Prevalent Vascular Retinal Diseases
  • Chapter 8
    Faulty Homocysteine Recycling in Diabetic Retinopathy
  • Chapter 9
    Exploring the Quality of Life Issues in People with Retinal Diseases: a Qualitative Study
  • Chapter 10
    A Personalised Screening Strategy for Diabetic Retinopathy: a Cost-Effectiveness Perspective
  • Chapter 11
    Assessment of Macular Findings by OCT Angiography in Patients without Clinical Signs of Diabetic Retinopathy: Radiomics Features for Early Screening of Diabetic Retinopathy
  • Chapter 12
    Mesenchymal Stem Cell-Based Therapy for Retinal Degenerative Diseases: Experimental Models and Clinical Trials
  • Chapter 13
    Optimizing Medical Management in Patients with Sight-Threatening Diabetic Retinopathy
  • Chapter 14
    Looking for In Vitro Models for Retinal Diseases
  • Chapter 15
    Clinical Features of Serous Retinopathy Observed with Cobimetinib in Patients with BRAF‑Mutated Melanoma Treated in the Randomized coBRIM Study
Readership: Students, academics, teachers and other people attending or interested in Retinopathy.
Kee-Yong Choi
Department of Ophthalmology, HanGil Eye Hospital, 35 Bupyeong-daero, Bupyeong-gu, Incheon 21388, Korea

Sonali Dey
Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore

Jason Lee
Department of Ophthalmology and Visual Sciences, Khoo Teck Puat Hospital, Singapore 768828, Singapore

Raja Narayanan
Director-The Retina Institute and Suven Clinical Research Centre, Consultant Ophthalmologist, Vitreo Retinal Diseases, Kallam Anji Reddy Campus, L V Prasad Eye Institute, Hyderabad, Telangana, India

Helen Colhoun
Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK

and more...
Copyright © 2006-2024 Scientific Research Publishing Inc. All Rights Reserved.
Top